Finzati - Logo
SBRA logo

Sabra Health Care REIT, Inc.

SBRA • REIT - Healthcare Facilities
$20.78
▼ -0.15 (-0.72%)
Current price
EarningsLatest report: Jun 30, 2026
FAVORABLE PROFILEAttractiveConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$5.21B
Growth
15.9%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 20.1%Positive revenue growth · 5.4%Positive free cash flow · 1.44Consistent free cash flow · 5/5Weak liquidity · 0.56
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$20.78
Change-0.72%
Market Cap$5.21B
52W Range17.17 - 22.77
Beta0.62
Gross Margin65.00%
Oper. Margin34.06%
Profit Margin20.09%
Debt/Eq0.90
Current Ratio0.56
Quick Ratio0.56
Revenue 5Y15.94%

Investment DNA

How strong this company looks for long-term investors

72
out of 100
Business Quality
Margins, moat, returns
90/100
Financial Strength
Debt, cash, stability
34/100
Growth Potential
Revenue and expansion
51/100
Price Attractiveness
Cheap or expensive today
66/100
Why this score▼
Stable or improving margins · 20.1%Positive revenue growth · 5.4%Positive free cash flow · 1.44Consistent free cash flow · 5/5Weak liquidity · 0.56

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-05
Low
$21.00
Mean
$22.50
Median
$22.00
High
$25.00

Company Overview

IPO: 4/2/2002
Industry: REIT - Healthcare Facilities
P/B i: 1.62
Debt / Equity i: 0.90
Operating Margin: 34.06%
Net Margin: 20.09%
ROE i: -
ROIC: -

Financial Health

Score7 / 20
Debt / Equity: 0.90
Current Ratio: 0.56
Quick Ratio: 0.56
Status: Weak

Warnings

  • Weak Liquidity
  • Weak quick ratio

Insider Transactions

Recent executive and insider activity

Barbarosh Craig A.
Transaction: 06/17/2026
BUY
Change
+8,310
Price
Not reported
Filing
06/18/2026
Type
BUY
Cusack Catherine
Transaction: 06/17/2026
BUY
Change
+8,310
Price
Not reported
Filing
06/18/2026
Type
BUY
FOSTER MICHAEL J
Transaction: 06/17/2026
BUY
Change
+8,310
Price
Not reported
Filing
06/18/2026
Type
BUY